Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Short-term Investments: 2022-2025

Historic Short-term Investments for Biofrontera (BFRI) over the last 3 years, with Sep 2025 value amounting to $10,000.

  • Biofrontera's Short-term Investments rose 25.00% to $10,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $10,000, marking a year-over-year increase of 25.00%. This contributed to the annual value of $7,000 for FY2024, which is 91.03% down from last year.
  • Biofrontera's Short-term Investments amounted to $10,000 in Q3 2025, which was up 11.11% from $9,000 recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Short-term Investments ranged from a high of $10.5 million in Q4 2022 and a low of $7,000 during Q4 2024.
  • Moreover, its 3-year median value for Short-term Investments was $10,000 (2025), whereas its average is $1.1 million.
  • As far as peak fluctuations go, Biofrontera's Short-term Investments tumbled by 99.76% in 2024, and later climbed by 25.00% in 2025.
  • Quarterly analysis of 4 years shows Biofrontera's Short-term Investments stood at $10.5 million in 2022, then plummeted by 99.26% to $78,000 in 2023, then tumbled by 91.03% to $7,000 in 2024, then increased by 25.00% to $10,000 in 2025.
  • Its Short-term Investments was $10,000 in Q3 2025, compared to $9,000 in Q2 2025 and $7,000 in Q1 2025.